Establishment of a cell line from a malignant rhabdoid tumor of the liver lacking the function of two tumor suppressor genes, hSNF5/INI1 and p16

Cancer Genetics and Cytogenetics

Volumn 158, Issue 2, 2005, Pages 172-179

  Kuroda, Hiroshi ^a,b   Moritake, Hiroshi ^c   Sawada, Kazumi ^c   Kuwahara, Yasumichi ^b   Imoto, Issei ^d   Inazawa, Johji ^d   Sugimoto, Tohru ^b  

^a KYOTO CITY HOSPITAL   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c UNIVERSITY OF MIYAZAKI   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALPHA ACTIN; ALPHA SMOOTH MUSCLE ACTIN; CYTOKERATIN; DESMIN; MYOD1 PROTEIN; MYOSIN HEAVY CHAIN; NEUROFILAMENT PROTEIN; PROTEIN P16; SMOOTH MUSCLE MYOSIN HEAVY CHAIN 1; SMOOTH MUSCLE MYOSIN HEAVY CHAIN 2; UNCLASSIFIED DRUG; VIMENTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER CELL CULTURE; CASE REPORT; CHROMOSOME 22Q; CHROMOSOME ABERRATION; CHROMOSOME BANDING PATTERN; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE FUNCTION; HOMOZYGOSITY; HSNF 5 GENE; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOID TUMOR; TUMOR SUPPRESSOR GENE;

EID: 15744394607     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2004.08.032     Document Type: Article

References (30)

1. J.B. Beckwith, and N.F. Palmer Histopathology and prognosis of Wilms' tumor: results from the first National Wilms' Tumor Study Cancer 41 1978 1937 1948
2. D.M. Parham, D.A. Weeks, and J.B. Beckwith The clinicopathologic spectrum of putative extrarenal rhabdoid tumors Am J Surg Pathol 18 1994 1010 1029
3. M.R. Wick, J.H. Ritter, and L.P. Dehner Malignant rhabdoid tumors: a clinicopathologic review and conceptual discussion Semin Diagn Pathol 12 1995 233 248
4. D.M. Parham, S.C. Peiper, G. Robicheaux, R.C. Ribeiro, and E.C. Douglass Malignant rhabdoid tumor of the liver: evidence for epithelial differentiation Arch Pathol Lab Med 112 1988 61 64
5. S.J. Hunt, and W.D. Anderson Malignant rhabdoid tumor of the liver: a distinct clinicopathologic entity Am J Clin Pathol 94 1990 645 648
6. S. Gururangan, L.C. Bowman, D.M. Parham, J.A. Williams, B. Rao, C.B. Pratt, and E.C. Douglass Primary extracranial rhabdoid tumors: clinicopathologic features and response to ifosphamide Cancer 71 1993 2653 2659
7. A. Pogacnik, and N. Zidar Malignant rhabdoid tumor of the liver diagnosed by fine needle aspiration cytology: a case report Acta Cytol 41 1997 539 543
8. D.M. Kelly, M. Jones, S. Humphreys, and E.R. Howard Spontaneous rupture of a malignant rhabdoid tumor of the liver Pediatr Surg Int 14 1998 111 112
9. H.M. Katzenstein, M. Kletzel, M. Reynolds, R. Superina, and F. Gonzalez-Crussi Metastatic malignant rhabdoid tumor of the liver treated with tandem high-dose therapy and autologous peripheral blood stem cell rescue Med Pediatr Oncol 40 2003 199 201
10. K.V. Ravindra, C. Cullinane, I.J. Lewis, B.R. Squire, and M.D. Stringer Long-term survival after spontaneous rupture of a malignant rhabdoid tumor of the liver J Pediatr Surg 37 2002 1488 1490
11. L.R. Donner, A. Rao, L.M. Truss, and S.M. Dobin Translocation (8;13) (q24.2;q33) in a malignant rhabdoid tumor of the liver Cancer Genet Cytogenet 116 2000 153 157
12. I. Versteege, N. Sevenet, J. Lange, M.F. Rousseau-Merck, P. Ambros, R. Handgretinger, A. Aurias, and O. Delattre Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer Nature 394 1998 203 206
13. J.A. Biegel, J.-Y. Zhou, L.B. Rorke, C. Stenstrom, L.M. Wainwright, and B. Fogelgren Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors Cancer Res 59 1999 74 79
14. M.F. Rousseau-Merck, I. Versteege, I. Legrand, J. Couturier, A. Marial, O. Delattre, and A. Aurias hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors Cancer Res 59 1999 3152 3156
15. K. Uno, J. Takita, K. Yokomori, Y. Tanaka, S. Ohta, H. Shimada, F.H. Gilles, K. Sugita, S. Abe, M. Sako, K. Hashizume, and Y. Hayashi Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors Genes Chromosomes Cancer 34 2002 33 41
16. T. Nobori, K. Miura, D.J. Wu, A. Lois, K. Takabayashi, and D.A. Carson Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers Nature 368 1994 753 756
17. A. Kamb, N.A. Gruis, J. Weaverfeldhaus, Q.Y. Liu, K. Harshman, S.V. Tavtigian, E. Stockert, R.S. Day, B.E. Johnson, and M.H. Skolnick A cell-cycle regulator potentially involved in genesis of many tumor types Science 264 1994 36 44
18. Y. Hayashi, T. Sugimoto, Y. Horii, H. Hosoi, J. Inazawa, J.T. Kemshead, T. Inaba, R. Hanada, K. Yamamoto, A.M. Gown, and T. Sawada Characterization of an embryonal rhabdomyosarcoma cell line showing amplification and over-expression of the N-myc oncogene Int J Cancer 45 1990 705 711
19. J. Takita, Y. Hayashi, T. Kohno, N. Yamaguchi, R. Hanada, K. Yamamoto, and J. Yokota Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in Neuroblastoma Cancer Res 57 1997 907 912
20. H. Kuroda, T. Sugimoto, K. Ueda, S. Tsuchida, Y. Horii, J. Inazawa, K. Sato, and T. Sawada Different drug sensitivity in two neuroblastoma cell lines established from the same patient before and after chemotherapy Int J Cancer 47 1991 732 737
21. J. Inazawa, T. Ariyama, and T. Abe Physical ordering of three polymorphic DNA markers spanning the regions containing a tumor suppressor gene of renal cell carcinoma by three-color fluorescent in situ hybridization Jpn J Cancer Res 83 1992 1248 1252
22. T. Ariyama, J. Inazawa, Y. Uemura, N. Kakazu, T. Maekawa, F. Urase, K. Irimajiri, A. Horiuchi, Y. Nakamura, and T. Abe Clonal origin of Philedelphia chromosome negative cells with trisomy 8 appearing during the course of alpha-interferon therapy for Ph positive chronic myelocytic leukemia Cancer Genet Cytogenet 81 1995 20 23
23. T. Sugimoto, H. Hosoi, Y. Horii, H. Ishida, H. Mine, K. Takahashi, T. Abe, S. Ohta, and T. Sawada Malignant rhabdoid-tumor cell line showing neural and smooth muscle cell phenotypes Int J Cancer 82 1999 678 686
24. M. Tsokos, G. Kouraklis, R.S. Chandra, B.S. Bhagavan, and T.J. Triche Malignant rhabdoid tumor of the kidney and soft tissues Arch Pathol Lab Med 113 1989 115 120
25. S. Ota, D.C.G. Crabbe, T.N. Tran, T.J. Triche, and H. Shimada Malignant rhabdoid tumor, a study with two established cell lines Cancer 71 1993 2862 2872
26. H. Hosoi, T. Sugimoto, Y. Hayashi, T. Inaba, Y. Horii, H. Morioka, S. Fushiki, M. Hamazaki, and T. Sawada Differential expression of myogenic regulatory genes, MyoD1 myogenin, in human rhabdomyosarcoma Int J Cancer 50 1992 977 983
27. D.E. Schofield, J.B. Beckwith, and J. Sklar Loss of heterozygosity at chromosome regions 22q11∼q12 and 11p15.5 in renal rhabdoid tumors Genes Chromosomes Cancer 15 1996 10 17
28. M. Aikawa, P.N. Sivam, M. Kuro-o, K. Kimura, K. Nakahara, S. Takewaki, M. Ueda, H. Yamaguchi, Y. Yazaki, M. Periasamy, and R. Nagai Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis Circulation Res 73 1993 1000 1012
29. A.P. Albino, B.M. Davis, and D.M. Nanus Induction of growth factor RNA expression in human malignant melanoma: markers of transformation Cancer Res 51 1991 4815 4820
30. R.L. Davis, H. Weintraub, and A.B. Lassar Expression of a single transfected cDNA converts fibroblasts to myoblasts Cell 51 1987 987 1000